These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6312958)

  • 1. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
    Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):7-10. PubMed ID: 3022711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance testing of clinical varicella-zoster virus strains.
    Sauerbrei A; Taut J; Zell R; Wutzler P
    Antiviral Res; 2011 Jun; 90(3):242-7. PubMed ID: 21539861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.
    Ng TI; Shi Y; Huffaker HJ; Kati W; Liu Y; Chen CM; Lin Z; Maring C; Kohlbrenner WE; Molla A
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1629-36. PubMed ID: 11353604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
    Biron KK; Fyfe JA; Noblin JE; Elion GB
    Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
    Yokota T; Konno K; Shigeta S; De Clercq E
    Mol Pharmacol; 1984 Sep; 26(2):376-80. PubMed ID: 6090888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human alpha, beta and gamma interferons on varicella zoster virus in vitro.
    Balachandra K; Thawaranantha D; Ayuthaya PI; Bhumisawasdi J; Shiraki K; Yamanishi K
    Southeast Asian J Trop Med Public Health; 1994 Jun; 25(2):252-7. PubMed ID: 7855636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
    Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
    Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
    Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
    J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.
    Talarico CL; Phelps WC; Biron KK
    J Virol; 1993 Feb; 67(2):1024-33. PubMed ID: 8380452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.
    Morfin F; Thouvenot D; De Turenne-Tessier M; Lina B; Aymard M; Ooka T
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2412-6. PubMed ID: 10508017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
    Shigeta S; Yokota T
    Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
    Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
    Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses.
    Frobert E; Cortay JC; Ooka T; Najioullah F; Thouvenot D; Lina B; Morfin F
    Antiviral Res; 2008 Jul; 79(1):28-36. PubMed ID: 18336925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.